VRXANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as VRXAW
Veraxa Biotech AG - Post de-SPAC
Last filing: 20-F on Jun 16, 2026
$1.00−0.11 (-9.91%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Statistics
Not enough reported data
Statistics need Veraxa Biotech AG - Post de-SPAC's reported income statement and balance sheet.